1515 Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
https://www.science.org/doi/10.1126/science.adl4793
1514 RANKL treatment restores thymic function and improves T cell–mediated immune responses in aged mice
https://www.science.org/doi/10.1126/scitranslmed.adp3171
1513 Transgelin 2 guards T cell lipid metabolism and antitumour function
https://www.nature.com/articles/s41586-024-08071-y
1512 Platelet factor 4–induced TH1-Treg polarization suppresses antitumor immunity
https://www.science.org/doi/10.1126/science.adn8608
1511 Disrupting the RNA polymerase II transcription cycle through CDK7 inhibition ameliorates inflammatory arthritis
https://www.science.org/doi/10.1126/scitranslmed.adq5091
1510 Monoclonal antibodies that block Roundabout 1 and 2 signaling target pathological ocular neovascularization through myeloid cells
https://www.science.org/doi/10.1126/scitranslmed.adn8388
1509 Monocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state
https://www.pnas.org/doi/10.1073/pnas.2404927121
1508 Structure-based design of glycoprotein subunit vaccines for mumps
https://www.pnas.org/doi/10.1073/pnas.2404053121
1507 In vivo human T cell engineering with enveloped delivery vehicles
https://www.nature.com/articles/s41587-023-02085-z
1506 Engineered serum markers for non-invasive monitoring of gene expression in the brain
https://www.nature.com/articles/s41587-023-02087-x
|
